Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Project Grant

University of Toronto

$956,250.00

Chemical technologies for controlling T cell glycosylation in health and disease

FY 2024-25

Summary
All cells in the human body are coated in a dense layer of carbohydrate molecules called glycans. Unlike nutritional carbohydates, glycans influence how cells communicate and advertise their health (or disease) status to other cells in the body. Recent work by us and others is revealing the molecular details of how glycans control specific immune responses; however, no therapeutics are currently approved that directly target these structures to treat diseases. We will address this gap in the therapeutic toolbox by synthesizing and validating new chemical material that can act at specific cellular pathways involved in making or destroying the glycans that are known to be involved in tuning immune responses. The results of this work will inform new therapeutic approaches to treat cancer.
Program
Project Grant
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
509075
Name
Edgar Landon J
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
Pharmacology & Toxicology
Projecttitle
Chemical technologies for controlling T cell glycosylation in health and disease
Programtype2
Operating Grants
Orgnameinp2
University of Toronto
Cihramount2
$956,250
Cihrequipment2
$0
Programname2
Project Grant
Keyworddelim
Autoimmunity; Cancer; Dendritic Cells; Glycocalyx; Glycosylation; Glycosyltransferases; Immunostimulant; Nucleotide Sugars; Sialic Acid; T Cells
Abstract
All cells in the human body are coated in a dense layer of carbohydrate molecules called glycans. Unlike nutritional carbohydates, glycans influence how cells communicate and advertise their health (or disease) status to other cells in the body. Recent work by us and others is revealing the molecular details of how glycans control specific immune responses; however, no therapeutics are currently approved that directly target these structures to treat diseases. We will address this gap in the therapeutic toolbox by synthesizing and validating new chemical material that can act at specific cellular pathways involved in making or destroying the glycans that are known to be involved in tuning immune responses. The results of this work will inform new therapeutic approaches to treat cancer.
Competitiondate
202409
Approvedterm2
5 yrs 0 mth
Pinamesdelim
Edgar, Landon J
Approvedterm
5 ans 0 mois
Cihrcontribution2
~ $956,250~ $0~